Literature DB >> 17560221

Changes in intestinal motility and in the myenteric plexus in a rat model of intestinal ischemia-reperfusion.

Marcia A C P Silva1, Luciana R de Meirelles, Joaquim M Bustorff-Silva.   

Abstract

BACKGROUND/
PURPOSE: Early histologic changes induced by intestinal ischemia-reperfusion injury (IIRI) have been extensively studied using animal models. However, information regarding late effects on intestinal motility is lacking. The aim of this study was to investigate the late effects of IIRI on myenteric plexus histology and intestinal motility.
MATERIALS AND METHODS: Thirty-two postweaning male rats weighing between 58 and 103 g were divided randomly into 4 groups: Control (unoperated), Sham (celiotomy), 30-minute ischemia (celiotomy and superior mesenteric artery ischemia for 30 minutes), and 45-minute ischemia (celiotomy and superior mesenteric artery ischemia for 45 minutes). Postoperative intestinal motility was assessed by weighing total fecal output for 24 hours on the 3rd, 7th, 14th, and 21st day after surgery. Segments of duodenum, jejunum, and ileum were examined at light microscopy for changes in the myenteric plexus.
RESULTS: Three weeks after IIRI, the ganglion cells from the myenteric plexus appeared in light microscopy, spongy or foamy, containing many vacuoles in their cytoplasm. The neuronal nucleus became irregular, with degenerative signs. These alterations did not occur among animals from the control or sham groups. Although the animals of the 45-minute ischemia group showed a significant drop in fecal output in the 21st postoperative day, this appeared to have no effect on weight gain.
CONCLUSIONS: The results suggest that intestinal ischemia-reperfusion causes late neuronal damage. These changes resulted in alterations of intestinal motility, which, within the conditions of the present study, had no repercussion on general weight gain.

Entities:  

Mesh:

Year:  2007        PMID: 17560221     DOI: 10.1016/j.jpedsurg.2005.07.009

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  6 in total

1.  Ketamine reduces intestinal injury and inflammatory cell infiltration after ischemia/reperfusion in rats.

Authors:  Francisco Javier Guzmán-De La Garza; Carlos Rodrigo Cámara-Lemarroy; Raquel Guadalupe Ballesteros-Elizondo; Gabriela Alarcón-Galván; Paula Cordero-Pérez; Nancy Esthela Fernández-Garza
Journal:  Surg Today       Date:  2010-11-03       Impact factor: 2.549

2.  Surgical acquired aganglionosis: myth or reality?

Authors:  M J Bag; T Sáez; J Varas; H Vallejos; D Meléndez; S Salas; Y Quiroga; F Villagrán; S Montedonico
Journal:  Pediatr Surg Int       Date:  2014-07-15       Impact factor: 1.827

3.  Detection of MAPK signal transduction proteins in an ischemia/reperfusion model of mouse intestine using in vivo cryotechnique.

Authors:  Jiaorong Chen; Nobuo Terada; Yurika Saitoh; Zheng Huang; Nobuhiko Ohno; Shinichi Ohno
Journal:  Histochem Cell Biol       Date:  2013-06-23       Impact factor: 4.304

4.  Resveratrol Reduces Morphologic Changes in the Myenteric Plexus and Oxidative Stress in the Ileum in Rats with Ischemia/Reperfusion Injury.

Authors:  Aline Cristine da Silva de Souza; Stephanie Carvalho Borges; Evandro José Beraldi; Anacharis Babeto de Sá-Nakanishi; Jurandir Fernando Comar; Adelar Bracht; Maria Raquel Marçal Natali; Nilza Cristina Buttow
Journal:  Dig Dis Sci       Date:  2015-06-16       Impact factor: 3.199

5.  Infiltration of mast cells in rat colon is a consequence of ischemia/reperfusion.

Authors:  Elin Sand; Anna Themner-Persson; Eva Ekblad
Journal:  Dig Dis Sci       Date:  2008-05-08       Impact factor: 3.199

6.  Global hypoxia-ischemia induced inflammation and structural changes in the preterm ovine gut which were not ameliorated by mesenchymal stem cell treatment.

Authors:  Maria Nikiforou; Carolin Willburger; Anja E de Jong; Nico Kloosterboer; Reint K Jellema; Daan R M G Ophelders; Harry W M Steinbusch; Boris W Kramer; Tim Wolfs
Journal:  Mol Med       Date:  2016-04-14       Impact factor: 6.354

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.